NIOX Group (LON:NIOX) Announces Earnings Results

NIOX Group (LON:NIOX) released its quarterly earnings results on Wednesday. The company reported GBX 1.41 EPS for the quarter, Digital Look Earnings reports. NIOX Group had a net margin of 14.74% and a return on equity of 10.01%.

NIOX Group Trading Up 1.8%

NIOX traded up GBX 1.19 during midday trading on Friday, reaching GBX 67.19. 125,783 shares of the company were exchanged, compared to its average volume of 795,874. The stock has a market capitalization of £282.76 million, a P/E ratio of 40.97 and a beta of 0.92. The stock’s 50-day simple moving average is GBX 65.75 and its 200 day simple moving average is GBX 61.67. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.94 and a current ratio of 4.60. NIOX Group has a one year low of GBX 53.84 and a one year high of GBX 76.

NIOX Group Company Profile

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.